Saving lives by developing novel nlrp3 based diagnostics and prognosis compact devices to enable hospitals' labs and physicians a faster and more acurate stratification of patients suffering septic shock and other acute inflammatary diseases. Scientific leadership by Dr. Pablo Pelegrín. Clinical team led by Dr. García-Palenciano. Market study by BHV Partners. Market field research by CiDi Salud. Instituto Murciano de Investigación Biosanitaria (IMIB)'s spinoff. Proof of Concept project granted by European Research Council.